Weed Inc's Comment on Competition and Industry Peers
The company identifies its competitors as entities engaged in studying and sequencing cannabis DNA to develop medicines, rather than those involved in cultivating or selling cannabis for medicinal or recreational purposes. Named competitors include TRUL, TerrAscend Corporation (OTCQX: TCNNF), and Tilray Brands, Inc. (OTCQX). The company highlights its research team with decades of experience, over 14,000 square feet of dedicated research space, advanced DNA sequencing instruments capable of sequencing large DNA fragments, and proprietary bioinformatics software. The competitive landscape also encompasses suppliers of synthetic cannabinoids and cannabis extracts for research, as well as companies cultivating cannabis for herbal or non-pharmaceutical uses. Other organizations and universities working on cannabis genomics may compete for research funding but are not considered direct competitors. Next-generation sequencing technologies referenced include Illumina (Solexa), Roche 454, Ion Torrent (Proton/PGM), and SOLiD sequencing.
Sources:
WEED, INC.’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on WEED, INC. versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
